School of Pharmaceutical
Sciences of Ribeirão Preto

University of São Paulo

LANGUAGES: | INTRANET

Publications

SCIENTIFIC ARTICLES ACCEPTED FOR PUBLICATION


SCIENTIFIC ARTICLES PUBLISHED IN JOURNAL

 

Rodrigues JPV, Marques FA, Gonçalves AMRF, Campos MSA, Reis TM, Morelo MRS, et al. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PLoS One. 2019;14(1):e0210779. https://www.ncbi.nlm.nih.gov/pubmed/30657771

 

Peres HA, Pereira LRL, Martinez EZ, Viana CM, Foss-Freitas MC. Heart failure is associated with non-adherence to pharmacotherapy in elderly with type 2 diabetes mellitus in public health system Brazilians. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):939–46. https://www.sciencedirect.com/science/article/pii/S1871402118305654

 

Peres HA, Leira Pereira LR, Viana CM, Foss-Freitas MC. Patient’s lack of understanding producing insulin drug-interactions in Southeast Brazilian primary care clinics. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):1131–6.   https://www.sciencedirect.com/science/article/pii/S1871402118306581

 

Barboza-Zanetti MO, Barboza-Zanetti AC, Rodrigues-Abjaude SA, Pinto-Simões B, Leira-Pereira LR. Clinical pharmacists’ contributions to hematopoietic stem cell transplantation: A systematic review. J Oncol Pharm Pract. 2019;25(2):423–33. https://www.ncbi.nlm.nih.gov/pubmed/29890918

 

Reis MAS, Gabriel CS, Zanetti ACB, Bernardes A, Laus AM, Pereira LRL. Pottentially hazardous drugs: identification of risks and error prevention barriers in intensive care.Texto Context - Enferm. 2018;27(2):e5710016. http://www.scielo.br/scielo.php?pid=S0104-07072018000200330&script=sci_arttext

 

 

Reis TM, Baldoni AO, Campos AM, Girotto E, Guidoni CM, Obrelli-Neto PR, et al. Effectiveness of a Distance Learning Course for Brazilian Community Pharmacists. Am J Pharm Educ . 2018;0(0). http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100605

 

Reis TM, Guidoni CM, Baldoni AO, Giroto E, Obreli Neto PR, Ayres LR, et al. Pharmacists in dispensing drugs (PharmDisp): protocol for a clinical trial to test the effectiveness of distance education in training pharmacists for dispensing drugs. Brazilian J Pharm Sci. 2018;54(1). http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100605

 

Reis TM, Zanetti ACB, Obreli-Neto PR, Gonçalves AMRF, Baldoni AO, Guidoni CM, et al. PHARMACISTS IN DISPENSING DRUGS (PharmDisp): construction and validation of a questionnaire to assess the knowledge for dispensing drug before and after a training course. Rev Eletrônica Farmácia. 2018;14(4). https://www.revistas.ufg.br/REF/article/view/45372/0

 

Baldoni AO, Freitas-Lima P, Alexandre V, Mota K de F, Martinez EZ, Sakamoto AC, et al. Quality of life and adverse events of patients with drug-resistant epilepsy using lamotrigine. Med (Ribeirão Preto, Online). 2018;51(3):177–88. http://revista.fmrp.usp.br/2018/vol51n3-2018/AO2-Qualidade-de-vida-e-eventos-adversos-Pacientes-em-uso-de-lamotrigina.pdf

Baldoni AO, Freitas-Lima P, Alexandre V, Ferreira FIS, Martinez EZ, Queiroz RHC, et al. Influence of the clinical profile of patients with refractory epilepsy on lamotrigine plasma concentration. Brazilian J Pharm Sci. 2018;54(2). http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000200624

 

Camargos AMT, Gonçalves ACO, Cazarim MS, Sanches C, Pereira LRL, Baldoni AO. Patients lacking glycemic control place more burdens on health services with the use of medications. Diabetes Metab Syndr Clin Res Rev. 2018;12(3):279–83. https://www.ncbi.nlm.nih.gov/pubmed/29273427

 

Campos MSA, Ayres LR, Morelo MRS, Carizio FAM, Pereira LRL. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int J Clin Pharm. 2018;40(3):589–98. https://www.ncbi.nlm.nih.gov/pubmed/29744790

 

Marques FA, Albuquerque NCP, Campos MSA, Freitas-Lima P, Baldoni AO, Alexandre Júnior V, et al. Drug-resistant epilepsy and topiramate: Plasma concentration and frequency of epileptic seizures. Clin Exp Pharmacol Physiol. 2018;45(7):652–8.  https://www.ncbi.nlm.nih.gov/pubmed/29424067

Pereira LB, Guidoni CM, Borges APS, Pereira LRL. Evaluation of the effectiveness of pharmacotherapy follow-up in long-term control of diabetes mellitus type 2. Clin Biomed Res. 2018;38(3). https://seer.ufrgs.br/hcpa/article/view/81089

Peres HA, Foss MCF, Pereira LRL, Viana CM. Association between Maternal Omega-3-Fatty Acid and Hypothyroidism: Unhealthy Baby and Brain Disorders. ARC J Nutr Growth. 2018;4(2).

Abjaude SAR, Silva LCM, Pereira LB, Pereira LRL. Use of Social Media for Education and Popularization of Science and Pharmaceutical Technologies. Rev Cult e Extensão - USP. 2018;17:39.

Cazarim MS, Nunes AA, Pereira LRL. Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil. Brazilian J Pharm Sci. 2018;53(3). http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300620

 

Cazarim MS, Pereira LRL. Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil. PLoS One. 2018;13(3):e0193567. https://www.ncbi.nlm.nih.gov/pubmed/29509802

 Chachá SGF, Rodrigues JPV, Araújo RC, Pereira LRL, Villanova MG, Souza FF, et al. First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients. Rev Soc Bras Med Trop. 2018;51(2):146–54. http://www.scielo.br/scielo.php?pid=S0037-86822018000200146&script=sci_arttext

Gomes LO, Teixeira MR, Rosa JA, Feltrin AA, Rodrigues JPV., Vecchi MD, et al. Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir. Rev Inst Med Trop Sao Paulo. 2018;60(0). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029893/

 

Guerra-Silva NMM, Santucci FS, Moreira RC, Tashima CM, Melo SCCS, Pereira LRL, et al. Comparison between cardiac risk scales in basic care for different populations. Int J Cardiol. 2018;266:270. https://www.internationaljournalofcardiology.com/article/S0167-5273(18)31896-5/abstract

Peres HA, Freita-Foss MC, Pereira LRL. Low Scores in the Auto-Compliance Method and Fast Medical Care Influence the Poor Adherence in Diabetics attended in the Basic Health Unit. Biol Med. 2017;9(3):1000398. https://www.longdom.org/open-access/heverton-alves-peres-maria-cristina-freitas-foss-and-leonardo-rgis-leira-pereira-0974-8369-1000398.pdf

 

Peres HA, Foss MCF, Pereira LRL, Viana CM. New Insights for the Polypharmacy Use in Elderly with Diabetes-An Update about Effect of Education Level. J Endocrinol Diab. 2017;4(5): 1-6. https://symbiosisonlinepublishing.com/endocrinology-diabetes/endocrinology-diabetes88.php

Cazarim MS, Rodrigues JPV, Cruz-Cazarim ELC, Ayres LR, Pereira LRL. Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system. Brazilian J Pharm Sci. 2017;53(3):e00178. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300616

 

Cazarim MS, Cruz-Cazarim ELC, Baldoni AO, Santos TBE, Souza PG, Silva IA, et al. Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2017;11:S859–65. https://www.ncbi.nlm.nih.gov/pubmed/28701284

 

Cazarim MS, Gonçalves ACO, Baldoni AO, Sanches C, Pereira LRL. Markov Prediction Model for the Main Complications of Type 2 Diabetes Mellitus – Open Access Journals| International Conferences. Endocr Pract. 2017;1:004. https://www.clytojournals.com/markov-prediction-model-main-complications-type-2-diabetes-mellitus

 

Cazarim MS, Reis R, Wu O, Rijo RPCL, Vinci ALT, Alves D, et al. Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS). Procedia Comput Sci. 2017;121:376–83. https://www.sciencedirect.com/science/article/pii/S1877050917322421

 

Guerra-Silva NMM, Santucci FS, Moreira RC, Tashima CM, Melo SCCS, Pereira LRL, et al. Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham. Int J Cardiol. 2017;228:481–7. https://www.ncbi.nlm.nih.gov/pubmed/27870979

 

Pereira LRL, Foss-Freitas MC, Peres HA, Martinez EZ. Age, the Number of Medicines Taken and Comorbidities are Associated with Changes of Fasting Blood Glucose Levels in Elderly Diabetics Taking Propranolol and Hydrochlorothiazide. J Bioanal Biomed. 2017;09(05):1–4.

 

Peres HA, Foss MCF, Pereira LRL. High Dosage Insulin, Low Adherence and Low Knowledge about Pharmacotherapy- Face To Face With Reality in the Health Public System Brazilians. Prensa Med Argent. 2017;103(4):1–5.

 

Rodrigues JPV, Aguiar BF, Pereira LRL. [Evolution of pharmacological treatment for chronic hepatitis C: from monotherapy with conventional interferon to new direct acting drugs] Evolução do tratamento farmacológico da Hepatite C crônica: da monoterapia com o Interferon convencional aos novos fármacos de ação direta. J Apllied Pharm Sci. 2017;4(2):1–7.

 

Ungari AQ, Pereira LRL, Nunes AA, Peria FM. Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school. BMC Cancer. 2017;17(1):691. https://www.ncbi.nlm.nih.gov/pubmed/29041915

Fonseca CL, Obreli-Neto PR, Baldoni AOReis TM, Rodrigues JPV, Pereira LRL, Girotto E, Guidoni CM. Clinical Pharmacy in Brazil: an integrative review. REVISTA BRASILEIRA DE FARMÁCIA (ON LINE). 2017;98:1826-1844. http://www.rbfarma.org.br/volume-98---n1.html


Peres HA, Foss-Freitas MC, Pereira lRL.  The Role of Coenzyme Q10 Supplementation with Statin Drug Use and Chronic Diseases. Journal of Infectious Diseases & Preventive Medicine. 2017;5:1-3. https://www.esciencecentral.org/journals/the-role-of-coenzyme-q10-supplementation-with-statin-drug-use-and-chronicdiseases-2329-8731-1000157.php?aid=86554

 

Obreli-Neto PR, Reis TM, Guidoni CM, Girotto E, Guerra ML, Baldoni AO, Pereira LRL. A Systematic Review of the Effects of Continuing Education Programs on Providing Clinical Community Pharmacy Services. American Journal of Pharmaceutical Education. 2016;80: 88.https://www.ncbi.nlm.nih.gov/pubmed/27402991

 

Reis TM, Campos MAS, Nagai MM, Pereira LRL. Contributions of pharmacists in the treatment of epilepsy: a systematic review. The American Journal of Pharmacy Benefits. 2016;8:55-60. http://www.ajpb.com/journals/ajpb/2016/ajpb_mayjune2016/contributions-of-pharmacists-in-the-treatment-of-epilepsy-a-systematic-review

 

Obreli-Neto PR, Guidoni CM, Baldoni AO, Marusic S, Castedalli G, Lahoud YM, Soares CF, Pereira LRL. Evaluation of the effectiveness of an Internet-based continuing education program on pharmacy-based minor ailment management: a randomized controlled clinical trial. Brazilian Journal of Pharmaceutical Sciences (Online). 2016;52:15-26. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000100003

 

Baldoni AO, Obreli-Neto PR, Guidoni CM, Pereira LRL. Perspectives for Clinical Pharmacy in Brazil. Journal of Applied Pharmaceutical Science. 2016;2:45-46.http://media.wix.com/ugd/e6f2ee_f7a36111ee204f61a67385791157bd17.pdf

 

Baldoni AO, Lima PF, Ferreira FIS, Alexandre Junior V, Martinez EZ, Queiroz RHC, Sakamoto AC, Perucca E, Pereira LRL. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy. Clinical and Experimental Pharmacology & Physiology. 2016;43:685-689.https://www.ncbi.nlm.nih.gov/pubmed/27120710

 

Cazarim MS, Moriguti JC, Ogunjimii A, Pereira LRL. Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances. São Paulo Medical Journal. 2016;134:342-354.https://www.ncbi.nlm.nih.gov/pubmed/27557144

 

Guidoni CM, Camargo HPM, Obreli-Neto PR, Girotto E, Pereira LRL. Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions. International. Journal of Clinical Pharmacy. 2016;1:3-6. https://link.springer.com/article/10.1007/s11096-016-0336-z

 

Chaves ND, Campos MAS, Rodrigues JPV, Alexandre Junior V, Pereira LRL. Epilepsy and quality of life: evaluation of temporal lobectomy patients with drug-resistant epilepsy.. Journal Of Epilepsy and Clinical Neurophysiology. 2016;22:46-49.http://epilepsia.org.br/wp-content/uploads/2017/01/REVISTA-JECN-V22-N2.pdf

 

Cazarim MS, Gonçalves ACO, Maduro LCS, Pereira LRL. Perspectives of Pharmacoeconomics to improve access to the Brazilian Public Health System. Journal of Applied Pharmaceutical Sciences. 2016;3:3-6.http://media.wix.com/ugd/e6f2ee_1375b4ec83ae47758e6b2c3a5f288220.pdf

 

Rodrigues JPV, Pereira LRL. Farmácia Clínica em Ambiente Hospitalar: Perspectivas e Estratégias para Implementação. Journal of Applied Pharmaceutical Sciences. 2016;3:7-10.http://media.wix.com/ugd/e6f2ee_a4d2471cd1e24406b4fbcaef4a85d097.pdf

 

Peres HA, Pereira LRL. Resistant Hypertension: An opportunity for the pharmaceutical develop pharmaceutical care. Revista de Ciências Farmacêuticas Básica e Aplicada. 2016;36:483-489.http://seer.fcfar.unesp.br/rcfba/index.php/rcfba/article/view/195

 

Zanetti AB, Gabriel CS, Bernardes A, Pereira LRL. Translation to Brazilian Portuguese and cultural adaptation of a questionnaire addressing high-alert medications. Revista Gaúcha de Enfermagem (Online). 2016;37:e59200.https://www.ncbi.nlm.nih.gov/pubmed/27783713

 

Peres HA, Pereira LRL, Foss-Freitas MC. Toxins, Malnutrition, Stress, Infections and Electromagnetic Pollution: Looking about New Perspectives in Development of Diseases. Journal of Nutrition & Food Sciences. 2016;6:1-7.https://www.omicsonline.org/open-access/toxins-malnutrition-stress-infections-and-electromagnetic-pollutionlooking-about-new-perspectives-in-development-of-diseases-2155-9600-1000559.php?aid=79660

 

Cazarim MS, De Freitas O, Penaforte TR, Achcar A, Pereira LRL. Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge. Plos One. 2016;11:e0155204.https://www.ncbi.nlm.nih.gov/pubmed/27304922

 

Silva NMMG, Santucci FS, Moreira RC, Massaotashima C, De Melo SCCS, Pereira LRL, De Mello Gonçales Sant'ana D. Coronary Disease Risk Assessment In Men: Comparison Between ASCVD Risk Versus Framingham. International Journal of Cardiology (Print). 2016;228:481-487.https://www.ncbi.nlm.nih.gov/pubmed/27870979

 

Campos MAS, Ayres LR, Morelo MRS, Marques FA, Pereira LRL. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses. PHARMACOTHERAPY. 2016;36:1255-1271.https://www.ncbi.nlm.nih.gov/pubmed/27779771

 

Abjaude SAR, Miele SF, Magalhães ZR, Pereira LRL. Factors that Motivate Healthcare Professionals to Report Adverse Drug Events: A Systematic Review. Pharmaceutical Medicine. 2016;1-8.https://link.springer.com/article/10.1007/s40290-016-0174-2

 

Obreli-Neto PR, Marusic S, Guidoni, CM, Baldoni AO, Renovato R, Pilger D, Cuman RKN, Pereira LRLP. Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary healthcare: a 36-month randomized, controlled clinical trial. Journal of Managed Care &Specialty Pharmacy. 2015;21:66-75.https://www.ncbi.nlm.nih.gov/pubmed/25562774

 

Vieira LB, Ueta JM, Pereira LRL. Adherence to medication before and after the use of a Drug-Dispensing System with usage control. Brazilian Journal of Pharmaceutical Sciences (Impresso). 2015;51:1-9.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000200329

 

Ayres LR, Campos, M.A. S.; Gozzo, T. O.; Martinez, E. Z.; Ungari, A. Q.; Andrade, J. M.; Pereira, L. R. L. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital. International Journal of Clinical Pharmacy. 2015;1:1.https://www.ncbi.nlm.nih.gov/pubmed/25637407

 

Rodrigues JPV, Ayres LR, Filipin MV, Oliveira JCN, Pereira LRL. Impact of the individualized pharmaceutical consultation service on the therapeutic response of HIV-infected patients to antiretroviral treatment. Journal of Applied Pharmaceutical Sciences – JAPHAC. 2015;2:18-28. http://media.wix.com/ugd/e6f2ee_6d6f555b96e1474798b0340b15128800.pdf

 

Reis TM, Rocha KSS, Barros IMC, Santos LMC, Paixao FP, Almeida FHO, Lyra Júnior DP, Pereira LRL. Pharmacists´ skills in conducting clinical services in community pharmacies in urban areas of Northeast Brazil. Latin American Journal of Pharmacy. 2015;34(4):725-731.http://www.latamjpharm.org/resumenes/34/4/LAJOP_34_4_1_12.pdf

 

Reis TM, Guidoni CM, Girotto E, Rascado RR, Mastroianni PC, Cruciol JM, Pereira LRL. Pharmaceutical care in Brazilian community pharmacies: knowledge and practice. African Journal of Pharmacy and Pharmacology. 2015;9:287-294.http://www.academicjournals.org/journal/AJPP/article-abstract/3DCDF4A51363

 

Ungari AQ, Pereira LRL, Perdoná GSC, Bettim BB, Nunes AA, Rapatoni L, Oliveira HF, Peria FM. Cost Evaluation of Metastatic Colorectal Cancer Treatment in the Brazilian Public Healthcare System. Journal Integrative Oncology. 2015;4:1-5.https://www.omicsgroup.org/journals/cost-evaluation-of-metastatic-colorectal-cancer-treatment-in-the-brazilianpublic-healthcare-system-2329-6771-1000136.php?aid=55000

 

Reis TM, Guidoni CM, Girotto E, Rascado RR, Mastroianni PC, Cruciol JM, Pereira LRL. Knowledge and conduct of pharmacists for dispensing of drugs in community pharmacies: a cross-sectional study. Brazilian Journal of Pharmaceutical Sciences. 2015;51(3):733-744. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000300733

 

Ayres, L. R.; Baldoni, A. O.; Borges, A. P. S.; Pereira, L. R. L. Adherence and discontinuation to oral hormonal therapy in patients with hormone receptor positive breast cancer: a review. International Journal of Clinical Pharmacy. 2014;36:45-54.https://www.ncbi.nlm.nih.gov/pubmed/23934310

 

Kubota K, Campos MAS, Pereira LRL. Analysis of health care to patients with viral hepatitis B and C in the State of Amapá, Brazil. Revista de Ciências Farmacêuticas Básica e Aplicada. 2014;35:597-605.http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/viewFile/3199/3199

 

Baldoni AO, Dewulf NLS, Santos V, Reis TM, Ayres LR, Pereira LRL. Access barriers to pharmaceutical services among the Elderly. Revista de Ciências Farmacêuticas Básica e Aplicada. 2014;35:615-621.http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/viewFile/3224/3224

 

Fontoura A, Ayres LR, Nagai MM, Dewulf NLS, Santos V, Martinez EZ, Pereira LRL. Prevalence of medication use among low risk pregnant women: a drug utilization study. African Journal of Pharmacy and Pharmacology. 2014;8:883-892. http://www.academicjournals.org/journal/AJPP/article-abstract/FD22CDD47504

 

Ungari AQ, Pereira LMV, Abramovicius AC, Pereira LRL, Forster AC, Grande MM. Strategies to guarantee the integrality in the perspective of Specialized Component of Pharmaceutical Assistance. Revista de Administração em Saúde. 2014;16(63). http://www.cqh.org.br/portal/pag/doc.php?p_ndoc=1355

 

Guidoni CM, Borges APS, Freitas O, Pereira LRL. Analysis of treatment of comorbidities and the profile of medical consultations for diabetes mellitus. Ciência e Saúde Coletiva. 2013;18:3015-3022. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232013001000026

 

Borges APS, Campos MAS, Pereira LRL. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA. INT J CLIN PHARM-NET. 2013;35:425-431. https://www.ncbi.nlm.nih.gov/pubmed/23430533

 

Baldoni AO, Ayres LR, Martinez EZ, Dewulf NLS, Santos V, Obreli-Neto PR, Pereira LRL. Pharmacoepidemiological profile and polypharmacy indicators in elderly. Brazilian Journal of Pharmaceutical Sciences. 2013;49:443-452. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000300006

 

Lima PF, Alexandre Junior V, Baldoni AO, Ferreira FIS, Terra V. C.; Girolineto, B. M. P.; Queiroz, R. H. C.; Pereira, L. R. L.; Sakamoto, A. C. Lamotrigine therapeutic drug monitoring in a tertiary epilepsy centre. Journal of Epilepsy and Clinical Neurophysiology. 2013;19:6-12. http://pesquisa.bvs.br/brasil/resource/pt/lil-754470

 

Lima PF, Baldoni AO, Alexandre Junior V, Pereira LRL, Sakamoto AC. Drug utilization profile in adult patients with refractory epilepsy at a tertiary referral centre in Brazil. Arquivos de Neuro-Psiquiatria. 2013;71:856-861 .http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013001200856

 

Obreli-Neto PR, Pereira LRL, Guidoni CM, Baldoni AO, Martins RC, Abreu JA, Aquino CB, Faria NS, Girotto E, Cuman RKN. Survey of Brazilian community pharmacist knowledge about combined oral contraceptives. African Journal of Pharmacy and Pharmacology. 2013;7:2214-2219, 2013.http://www.academicjournals.org/journal/AJPP/article-abstract/9E2A21125974

 

Obreli-Neto PR, Pereira LRL, Guidoni CM, Baldoni AO, Marusic S, Lyra Júnior DP, Almeida K L, Pazete ACM, Nascimento JD, Kos M, Girotto E, Cuman RKN. Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists. Plos One. 2013;8:e79875. https://www.ncbi.nlm.nih.gov/pubmed/24324584

 

Baldoni AO, Ayres LR, Dewulf NLS, Santos, V, Martinez EZ, Pereira LRL. Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. International Journal of Clinical Pharmacy. 2013;11:1-11. https://www.ncbi.nlm.nih.gov/pubmed/24271923

 

Guidoni CM, Obreli-Neto PR, Pereira LRL. Pharmacoepidemiologic study of warfarin prescription in a Brazilian tertiary hospital. Journal of Thrombosis and Thrombolysis. 2013;37:542-548.https://www.ncbi.nlm.nih.gov/pubmed/24264960

 

Pereira LRL, Freitas O, Netto MUQ. Antidepressivos e benzodiazepínicos: estudo sobre o uso racional entre usuários do SUS em Ribeirão Preto-SP. Revista de Ciências Farmacêuticas Básica e Aplicada. 2012;33:77-81. http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/viewFile/1777/1777

 

Guidoni CM, Pereira LRL. Sibutramine versus Metformin: evaluation of anthropometric, lipidic and glicaemic parameters in obese patients. Revista de Ciências Farmacêuticas Básica e Aplicada. 2012;33(1):49-55. http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/1695

 

Guidoni CM, Borges APS, Freitas O, Pereira LRL. Prescription patterns and therapeutic implications for Diabetes Mellitus: a population based analysis. Arquivos Brasileiros de Endocrinologia e Metabologia. 2012;56:120-127. https://www.ncbi.nlm.nih.gov/pubmed/22584565

 

Girolineto BMP, Alexandre Junior V, Sakamoto AC, Pereira LRL.  Interchangeability among therapeutic equivalents of lamotrigine: evaluation of quality of life. Brazilian Journal of Pharmaceutical Sciences. 2012;48:95-102.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000100011

 

Obreli-Neto PR, Baldoni AO, Guidoni CM, Bergamini D, Hernandes KC, Luz RT, Silva FB, Silva RO, Pereira LRL, Cuman RKN. Métodos de avaliação de adesão à farmacoterapia. Revista Brasileira de Farmácia. 2012;93:403-410. http://www.rbfarma.org.br/files/rbf-2012-93-4-2.pdf

 

Lima PF, Alexandre Junior V, Pereira LRL, Feletti F, Perucca E, Sakamoto AC. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy. Epilepsy Research. 2011;94:117-120. https://www.ncbi.nlm.nih.gov/pubmed/21282041

 

Girolineto BMP, Alexandre Junior V, Queiroz RHC, Feletti F, Sakamoto AC, Pereira LRL. Cartas al diretor: Intercambiabilidad entre equivalentes terapéuticos de lamotrigina. Réplica. Revista de Neurología. 2011;52:320-320. http://www.neurologia.com/articulo/2011009

 

Baldoni AO, Pereira LRL. O impacto do envelhecimento populacional brasileiro para o sistema de saúde sob a óptica da farmacoepidemiologia: uma revisão narrativa. Revista de Ciências Farmacêuticas Básica e Aplicada. 2011;32:313-321. http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/viewArticle/1505

 

Baldoni A, Guidoni CM, Pereira LRL. A Farmacoepidemiologia no Brasil: Estado da Arte da Produção Científica. Revista da Universidade Vale do Rio Verde. 2011;9:78-88. http://periodicos.unincor.br/index.php/revistaunincor/article/view/79

 

Borges APS, Guidoni CM, Freitas O, Pereira LRL. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arquivos Brasileiros de Endocrinologia e Metabologia. 2011;55:686-691. https://www.ncbi.nlm.nih.gov/pubmed/22231970

 

Martins ALT, Baldoni AO, Freitas O, Pereira LRL. Análise do perfil dos usuários de hidroclorotiazida assistidos no Sistema Único de Saúde de um município de São Paulo-Brasil. Revista Brasileira de Farmácia. 2011;92:373-377. http://www.rbfarma.org.br/files/rbf-2011-92-4-22-373-377.pdf

 

Guidoni CM, Baldoni AO, Obreli-Neto PR, Pereira LRL. Fontes De Informações Sobre Interações Medicamentosas: Há Concordância Entre Elas?. Revista da Universidade Vale do Rio Verde. 2011;9:84-91. http://periodicos.unincor.br/index.php/revistaunincor/article/view/238

 

Borges APS, Guidoni CM, Ferreira LD, Freitas O, Pereira LRL. The Pharmaceutical care of patients with type 2 diabetes mellitus. Pharmacy World & Science. 2010; 32(6):730-6. https://www.ncbi.nlm.nih.gov/pubmed/20734138

 

Baldoni AO, Chequer FMD, Ferraz ER. A.; Oliveira, D. P.; Pereira, L. R. L.; Dorta, D. J. Elderly and drugs: risks and necessity of rational use. Brazilian Journal of Pharmaceutical Sciences. 2010;46:617-632. http://www.scielo.br/pdf/bjps/v46n4/03.pdf

 

Girolineto BMP, Alexandre Junior V, Queiroz RHC, Feletti F, Sakamoto AC, Pereira LRL. Interchangeability among therapeutics equivalents of lamotrigine in the treatment of refractory epilepsy patients: risks and benefits. Revista de Neurología. 2010;51:330-336. https://www.ncbi.nlm.nih.gov/pubmed/20839169

 

Olivera CMX, Cesarino EJ, Freitas O, Pereira LRL. Padrões de Prescrição de Inibidores da Enzima Conversora da Angiotensina para Usuários do Sistema Único de Saúde. Revista Brasileira de Cardiologia. v. 23, p. 171-177, 2010.http://sociedades.cardiol.br/socerj/revista/2010_03/a2010_v23_n03_03carolina.pdf

 

Kawano DF, Ueta J, Sankarankutty AK, Pereira LRL, Freitas O. Midazolam-Related Drug Interactions: Detection of risk situations to the patient safety in a Brazilian Teaching Hospital. Journal of Patient Safety. 2009;5:69-74. https://www.ncbi.nlm.nih.gov/pubmed/19920444

 

Guimarães C, Pereira LRL, Martinez EZ, Cesarino EJ, Queiroz RHC. Benefícios do Tratamento Farmacológico da Fluoxetina em Mulheres Obesas. SIICsalud (Buenos Aires). 2009;13: 96239. http://www.siicsalud.com/dato/experto.php/96239

 

Dewulf NLS, Santos V, Pereira LRL, Troncon LEA. The Invisible Pharmacist. American Journal of Pharmaceutical Education. 2009;73:2-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720371/

 

Pereira LRL, Guidoni CM, Olivera CMX, Freitas O. Assistência ao diabetes no Sistema Único de Saúde: análise do modelo atual. Brazilian Journal of Pharmaceutical Sciences. 2009;45: 37-48. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502009000100005

 

Souza MC, Pereira LRL, Sakamoto CAM, Lima RCA, Santos TR, Lopes WDZ, Silva HM, Costa AJ. Farmacocinética de uma nova formulação de doramectina 3,5% em bovinos. A Hora Veterinária. 2009;29:5-10.

 

Pereira LRL, Freitas O. A Evolução da Atenção Farmacêutica e a perspectiva para o Brasil. Revista Brasileira de Ciências Farmacêuticas. 2008;44:601-612. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-93322008000400006

 

Pereira LRL, Araújo ALA, Ueta JM, Freitas O. Perfil da assistência farmacêutica na atenção primária do Sistema Único de Saúde. Ciência e Saúde Coletiva. 2008;13:611-617. http://www.scielo.br/scielo.php?pid=S1413-81232008000700010&script=sci_abstract&tlng=pt

 

Pereira LRL, Velasco TR, Sakamoto AC, Carvalho D. Evaluation of the drug interaction between carbamazepine and lamotrigine in the treatment of refractory epilepsy patients. Revista de Neurología. 2006;43(2):73-77. https://www.ncbi.nlm.nih.gov/pubmed/16838253

 

Kawano DF, Pereira LRL, Ueta JM, Freitas O. Acidentes com os medicamentos: como minimizá-los? Brazilian Journal of Pharmaceutical Sciences. 2006;42:487-495. http://bvsms.saude.gov.br/bvs/is_digital/is_0207/pdfs/IS27(2)042.pdf

 

Guimarães C, Pereira LRL, Lucif Júnior N, Cesarino EJ, Queiroz RHC, Carvalho D. Tolerability and Effectiveness of Fluoxetine, Metformin and Sibutramine in Reducing Anthropometric and Metabolic Parameters in Obese Patients. Arquivos Brasileiros de Endocrinologia & Metabologia. 2006;50(6):1020-1025.https://www.ncbi.nlm.nih.gov/pubmed/17221107

 

Pereira LRL, Queiroz RHC, Bianchi MLP, Lucif Júnior N. Eficácia de la sibutramina en la resistencia insulínica y el control glucémico de pacientes obesos. Seguimiento Farmacoterapéutico. 2005;3(4):225-231. http://www.redalyc.org/pdf/690/69030406.pdf

 

Pereira LRL, Andrade RCG, Pereira JGC, Marchetti JM. Avaliação das prescrições de pacientes portadores de diabetes mellitus atendidos por uma Unidade Básica de Saúde. Revista de Ciências Farmacêuticas Básica e Aplicada. 2005;26(3):199-203. http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/viewArticle/423

 

Pereira LRL, Baptista MEC, Carvalho D, Vecchi LUP. Avaliação da utilização de medicamentos em pacientes idosos, através dos conceitos de farmacoepidemiologia e farmacovigilância. Ciência e Saúde Coletiva. 2004;9:479-481. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232004000200023

 

Pereira LRL, Carvalho D, Baptista MEC. A Importância da Atenção Farmacêutica em Pacientes Hipertensos e Diabéticos Atendidos em Ambulatório Multi-Profissional. Infarma. 2003;15:75-77. http://revistas.cff.org.br/?journal=infarma&page=article&op=view&path%5B%5D=818&path%5B%5D=598

 

Queiróz MEC, Machado Neto JG, Pereira LRL, Calixto F, Amarolli FD, Arakawa NS,  Carvalho D. Safety measures in the application of organophosphate insecticides on staked tomato crops used dragged hoses. Bulletin of Environmental Contamination and Toxicology. 2002;7(4):68-73.https://link.springer.com/article/10.1007/s001280281

 

Pereira LRL, Barbosa RG, Couto LB, Rezende PCB, Costa AJ. Determinação de ivermectina em amostras de plasma bovino para fins de estudo de bioequivalência. ARS Veterinária. 2009;16:112-117. http://www.arsveterinaria.org.br/arquivo/2000/v.16,%20n.2,%202000/112-117.pdf

 

Pereira LRL, Barbosa RG, Couto LB, Paulilo AC, Queiróz MEC, Costa AJ, Carvalho D. Biodisponibilidade de sulfóxido de albendazol (2,5 e 3,4 mg/kg) em bovinos, naturalmente infectados por nematódeos parasitos. ARS Veterinária. 1999;15:7-11